Literature DB >> 9819405

Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

V Gelmetti1, J Zhang, M Fanelli, S Minucci, P G Pelicci, M A Lazar.   

Abstract

Nuclear receptor corepressor (CoR)-histone deacetylase (HDAC) complex recruitment is indispensable for the biological activities of the retinoic acid receptor fusion proteins of acute promyelocytic leukemias. We report here that ETO (eight-twenty-one or MTG8), which is fused to the acute myelogenous leukemia 1 (AML1) transcription factor in t(8;21) AML, interacts via its zinc finger region with a conserved domain of the corepressors N-CoR and SMRT and recruits HDAC in vivo. The fusion protein AML1-ETO retains the ability of ETO to form stable complexes with N-CoR/SMRT and HDAC. Deletion of the ETO C terminus abolishes CoR binding and HDAC recruitment and severely impairs the ability of AML1-ETO to inhibit differentiation of hematopoietic precursors. These data indicate that formation of a stable complex with CoR-HDAC is crucial to the activation of the leukemogenic potential of AML1 by ETO and suggest that aberrant recruitment of corepressor complexes is a general mechanism of leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819405      PMCID: PMC109300          DOI: 10.1128/MCB.18.12.7185

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.

Authors:  B Lutterbach; D Sun; J Schuetz; S W Hiebert
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 2.  The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes.

Authors:  P A Grant; D E Sterner; L J Duggan; J L Workman; S L Berger
Journal:  Trends Cell Biol       Date:  1998-05       Impact factor: 20.808

3.  SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex.

Authors:  Y Zhang; Z W Sun; R Iratni; H Erdjument-Bromage; P Tempst; M Hampsey; D Reinberg
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

4.  Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Authors:  M S Petrovick; S W Hiebert; A D Friedman; C J Hetherington; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 5.  Conjunction dysfunction: CBP/p300 in human disease.

Authors:  R H Giles; D J Peters; M H Breuning
Journal:  Trends Genet       Date:  1998-05       Impact factor: 11.639

Review 6.  Co-activators and co-repressors in the integration of transcriptional responses.

Authors:  J Torchia; C Glass; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1998-06       Impact factor: 8.382

7.  SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors.

Authors:  C D Laherty; A N Billin; R M Lavinsky; G S Yochum; A C Bush; J M Sun; T M Mullen; J R Davie; D W Rose; C K Glass; M G Rosenfeld; D E Ayer; R N Eisenman
Journal:  Mol Cell       Date:  1998-07       Impact factor: 17.970

8.  Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.

Authors:  I Kitabayashi; A Yokoyama; K Shimizu; M Ohki
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

9.  Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.

Authors:  R T Utley; K Ikeda; P A Grant; J Côté; D J Steger; A Eberharter; S John; J L Workman
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

10.  A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.

Authors:  H Y Kao; P Ordentlich; N Koyano-Nakagawa; Z Tang; M Downes; C R Kintner; R M Evans; T Kadesch
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  158 in total

1.  Transcriptional repression by the insulator protein CTCF involves histone deacetylases.

Authors:  M Lutz; L J Burke; G Barreto; F Goeman; H Greb; R Arnold; H Schultheiss; A Brehm; T Kouzarides; V Lobanenkov; R Renkawitz
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

Review 4.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

5.  Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.

Authors:  Heidi J Nick; Hyung-Gyoon Kim; Chia-Wei Chang; Kevin W Harris; Vishnu Reddy; Christopher A Klug
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

6.  Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

Authors:  Ming Yan; Sebastien A Burel; Luke F Peterson; Eiki Kanbe; Hiromi Iwasaki; Anita Boyapati; Robert Hines; Koichi Akashi; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

7.  Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.

Authors:  Ty C Voss; Ignacio A Demarco; Cynthia F Booker; Richard N Day
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

8.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

9.  Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Authors:  Tim Thomas; Lynn M Corcoran; Raffi Gugasyan; Mathew P Dixon; Thomas Brodnicki; Stephen L Nutt; Donald Metcalf; Anne K Voss
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

10.  Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.

Authors:  Yuki Kagiyama; Jiro Kitaura; Katsuhiro Togami; Tomoyuki Uchida; Daichi Inoue; Toshihiro Matsukawa; Kumi Izawa; Kimihito C Kawabata; Yukiko Komeno; Toshihiko Oki; Fumio Nakahara; Katsuaki Sato; Hiroyuki Aburatani; Toshio Kitamura
Journal:  Int J Hematol       Date:  2012-10-25       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.